Schedule 13G ownership disclosure

Xeris Biopharma Holdings Inc

Security class unavailable · CUSIP: 98422E103

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,195,189
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000138
Form type
SC 13G/A
Filer
Stonepine Capital Management, LLC
CIK
CIK 1440771
Filed
Feb 13, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub